WASHINGTON – The Senate Judiciary Committee has scheduled a Nov. 30 hearing to discuss pricing policies for the Mylan Pharmaceuticals EpiPen epinephrine injector that led to a $465 million settlement with the government.
Judiciary Committee member Amy Klobuchar was among those who called for the hearing.
The hearing will also focus on the misclassification of EpiPen as a generic, a designation that Klobuchar and others said allowed the company to receive more money from the federal Medicaid program than it should have.
![Attendees of Frostbike made their way through the convention Saturday at the Quality Bike Products campus in Minneapolis. ] (AARON LAVINSKY/STAR TRIBUNE) aaron.lavinsky@startribune.com Frostbike 2016 was held at the Quality Bike Products Campus on Saturday, Feb. 27, 2016 in Bloomington, Minn.](https://arc.stimg.co/startribunemedia/NH2BSHB74ND2V6GF2G2HI5X4MM.jpg?&w=252&ar=3:2&fit=crop)
